Skip to content
A8838Assembly2021-2022 SessionSame asS7837

Regulate Pharmacy Benefit Managers

Official title

“Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation”

Sponsor Richard GottfriedAD-75+1 co-sponsorAffects Legal
Status
Assembly Floor Calendar
Impact
8/10
Significant
Outcome
Companion signed

Bill progress

Signed via S7837

What's happening

This bill strengthens regulations, oversight, licensing, and transparency requirements for pharmacy benefit managers in New York State.

Why it matters

  1. Expanded oversight and accountability. The bill gives the Department of Financial Services (DFS) greater authority to define what constitutes a "substantial number of beneficiaries," regulate administrative fees, require more detailed reporting, and set minimum licensing standards—making it harder for pharmacy benefit managers (PBMs) to operate with opaque or unfair practices.

  2. Tougher penalties and restitution requirements. Penalties for unregistered or unlicensed activity are increased sharply (from $1,000 to $4,000 for first offenses, and from $2,500 to $10,000 for subsequent ones), and PBMs can now be ordered to pay restitution and compensatory damages to anyone harmed by their violations—including pharmacies, patients, and health plans.

  3. Stronger transparency and disclosure rules. PBMs must now share more financial data with the state and health plans, including rebates, fees, and contract terms. The bill also clarifies that labeling something as “proprietary” does not shield it from being provided to regulators for oversight.

  4. Expanded protections for consumers and pharmacies. The bill prohibits PBMs from restricting pharmacists' ability to inform customers about lower-cost alternatives or charging copays that exceed the cost of the drug. It also makes PBMs responsible for the actions of affiliates and subcontractors, and directs regulators to promote access to independent and community pharmacies and combat anti-competitive practices.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Regulate Pharmacy Benefit Managers

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Richard Gottfried

Assembly Member · Assembly District 75

1 Co-sponsor

History

  1. Substituted by S7837
  2. Advanced to third reading cal.403
  3. Reported
  4. Reported referred to ways and means
  5. Reported referred to codes
  6. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S7837Senate

Regulate Prescription Drug Middlemen

Signed by Governor · Sponsor Neil D. Breslin

Impact 8 · SignificantSigned into law

Full text

13 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8838

IN ASSEMBLY

January 13, 2022

Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; to amend the state finance law, in relation to establishing the pharmacy… Show all

AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; to amend the state finance law, in relation to establishing the pharmacy benefit manager regulatory fund; and to amend a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S.3762 and A.1396, in relation to the effectiveness thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivisions 1, 2, 3 and 5 of section 280-a of the public health law, as added by a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S. 3762 and A. 1396, are amended to read as follows:

1. Definitions. As used in this section, the following terms shall have the following meanings:

(a) "Health plan [or provider]" means an entity for which a pharmacy benefit manager provides pharmacy benefit management [including, but not limited to: (i)] services and that is a health benefit plan or other entity that approves, provides, arranges for, or pays or reimburses in whole or in part for health care items or services, [under which] to include at least prescription drugs, for a substantial number of beneficiaries [of the entity are purchased or which provides or arranges reimbursement in whole or in part for the purchase of prescription drugs; or (ii) a health care provider or professional that acquires prescription drugs to use or dispense in providing health care to patients where the prescription drug is the subject of the pharmacy

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00570-04-2

benefit manager's pharmacy benefit management services] who work or reside in this state. The superintendent shall determine, in his or her sole discretion, by regulation how the phrase "a substantial number of beneficiaries who work or reside in this state" shall be interpreted.

(b) "Pharmacy benefit management services" means the [service provided to] management or administration of prescription drug benefits for a health plan [or provider], directly or through another entity, and regardless of whether the pharmacy benefit manager and the health plan [or provider] are related, or associated by ownership, common ownership, organization or otherwise; including the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits, including but not limited to, any of the following:

(i) mail service pharmacy;

(ii) claims processing, retail network management, or payment of claims to pharmacies for dispensing prescription drugs;

(iii) clinical or other formulary or preferred drug list development or management;

(iv) negotiation or administration of rebates, discounts, payment differentials, or other incentives, for the inclusion of particular prescription drugs in a particular category or to promote the purchase of particular prescription drugs;

(v) patient compliance, therapeutic intervention, or generic substitution programs;

(vi) disease management;

(vii) drug utilization review or prior authorization;

(viii) adjudication of appeals or grievances related to prescription drug coverage;

(ix) contracting with network pharmacies; and

(x) controlling the cost of covered prescription drugs.

(c) "Pharmacy benefit manager" means any entity that performs pharmacy benefit management services for a health plan [or provider].

(d) "Maximum allowable cost price" means a maximum reimbursement amount set by the pharmacy benefit manager for therapeutically equivalent multiple source generic drugs.

(e) "Controlling person" means any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.

(f) "Covered individual" means a member, participant, enrollee, contract holder or policy holder or beneficiary of a health plan [or provider].

(g) "License" means a license to be a pharmacy benefit manager, under article twenty-nine of the insurance law.

(h) "Spread pricing" means the practice of a pharmacy benefit manager retaining an additional amount of money in addition to the amount paid to the pharmacy to fill a prescription.

(i) "Superintendent" means the superintendent of financial services.

2. Duty, accountability and transparency. (a) (i) The pharmacy benefit manager shall have a duty and obligation to [the covered individual and the health plan or provider, and shall] perform pharmacy benefit management services with care, skill, prudence, diligence, and professionalism[, and for the best interests of the covered individual, and the health plan or provider. Where there is a conflict in the pharmacy benefit manager's duty or obligation under this paragraph to the covered individual and any other party, the duty or obligation to the covered individual shall be primary].

(ii) In addition to the duties as may be prescribed by regulation pursuant to article twenty-nine of the insurance law:

(1) A pharmacy benefit manager interacting with a covered individual shall have the same duty to a covered individual as the health plan for whom it is performing pharmacy benefit management services.

(2) A pharmacy benefit manager shall have a duty of good faith and fair dealing with all parties, including but not limited to covered individuals and pharmacies, with whom it interacts in the performance of pharmacy benefit management services.

(b) All funds received by the pharmacy benefit manager in relation to providing pharmacy benefit management services shall be received by the pharmacy benefit manager in trust [for the health plan or provider] and shall be used or distributed only pursuant to the pharmacy benefit manager's contract with the health plan [or provider] or applicable law; including any administrative fee or payment to the pharmacy benefit manager expressly provided for in the contract to compensate the pharmacy benefit manager for its services. Any funds received by the pharmacy benefit manager through spread pricing shall be subject to this paragraph. In addition to any other power conferred by law the superintendent shall have the authority to prescribe rules concerning pharmacy benefit manager administrative fees, including limitations on their form and use.

(c) The pharmacy benefit manager shall account, annually or more frequently to the health plan [or provider] for any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees, grants, chargebacks, reimbursements, or other benefits received by the pharmacy benefit manager. [The pharmacy benefit manager shall ensure that any portion of such income, payments, and financial benefits is passed through to the health plan or provider in full to reduce the reportable ingredient cost.] The health plan [or provider] shall have access to all financial and utilization information of the pharmacy benefit manager in relation to pharmacy benefit management services provided to the health plan [or provider].

(d) The pharmacy benefit manager shall disclose in writing to the health plan [or provider] the terms and conditions of any contract or arrangement between the pharmacy benefit manager and any party relating to pharmacy benefit management services provided to the health plan [or provider] including but not limited to, dispensing fees paid to the pharmacies.

(e) The pharmacy benefit manager shall disclose in writing to the health plan [or provider] any activity, policy, practice, contract or arrangement of the pharmacy benefit manager that directly or indirectly presents any conflict of interest with the pharmacy benefit manager's relationship with or obligation to the health plan [or provider].

(f) Any information required to be disclosed by a pharmacy benefit manager to a health plan [or provider] under this section that is reasonably designated by the pharmacy benefit manager as proprietary or trade secret information shall be kept confidential by the health plan [or provider], except as required or permitted by law, including disclosure necessary to prosecute or defend any legitimate legal claim or cause of action. Designation of information as proprietary or trade secret information under this subdivision shall have no effect on the obligations of any pharmacy benefit manager or health plan to provide that information to the department of health or the department of financial services.

(g) The superintendent, in consultation with the commissioner[:

(i)] may make regulations defining, limiting, and relating to the duties, obligations, requirements and other provisions relating to pharmacy benefit managers under this subdivision[; and

(ii) shall establish, by regulation, minimum standards for pharmacy benefit management services which shall address the elimination of: conflicts of interest between pharmacy benefit managers and covered individuals, health benefit plans and health care providers; spread pricing; and deceptive practices, anti-competitive practices, and unfair claims practices.

(h) A health care provider and a covered individual shall be deemed to be third-party beneficiaries of the duties, obligations and requirements applicable to the pharmacy benefit manager under this section and shall be entitled to legal or equitable relief for any injury or loss to the health care provider or the covered individual caused by any violation of such duties, obligations or requirements].

3. Prescriptions. A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval of the prescriber or as explicitly required or permitted by law, including regulations of the department of financial services or the department of health. The superintendent and commissioner, in coordination with each other, are authorized to promulgate regulations to determine when substitution of prescription drugs may be required or permitted.

5. Contract provisions. No pharmacy benefit manager shall, with respect to contracts between such pharmacy benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization:

(a) prohibit or penalize a pharmacist or pharmacy from disclosing to an individual purchasing a prescription medication information regarding:

(i) the cost of the prescription medication to the individual, or

(ii) the availability of any therapeutically equivalent alternative medications or alternative methods of purchasing the prescription medication, including but not limited to, paying a cash price; or

(b) charge or collect from an individual a copayment that exceeds the total submitted charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or recoup the adjudicated cost[; or

(c) require a pharmacy to meet any pharmacy accreditation standard or recertification requirement inconsistent with, more stringent than, or in addition to federal and state requirements for licensure as a pharmacy].

§ 2. Article 29 of the insurance law, as added by a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S. 3762 and A. 1396, is amended to read as follows:

ARTICLE 29

PHARMACY BENEFIT MANAGERS Section 2901. Definitions.

2902. Acting without a registration.

2903. Registration requirements for pharmacy benefit managers.

2904. Reporting requirements for pharmacy benefit managers.

2905. Acting without a license.

2906. Licensing of a pharmacy benefit manager.

2907. Revocation or suspension of a registration or license of a

pharmacy benefit manager.

2908. Penalties for violations.

2909. Stay or suspension of superintendent's determination.

2910. Revoked registrations or licenses.

2911. Additional obligations.

2912. Change of address.

[2912.] 2913. Applicability of other laws.

[2913.] 2914. Assessments.

§ 2901. Definitions. For purposes of this article:

(a) "Controlling person" is any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.

(b) The terms "covered individual", "health plan [or provider]", "pharmacy benefit manager" and "pharmacy benefit management services" have the same meanings as defined by section two hundred eighty-a of the public health law. The superintendent is expressly authorized to interpret these terms as if the definitions were stated within this article.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.